Home » Stocks » AVCO

Avalon GloboCare Corp. (AVCO)

Stock Price: $1.12 USD -0.04 (-3.45%)
Updated Oct 30, 2020 11:38 AM EDT - Market open

Stock Price Chart

Key Info

Market Cap 89.68M
Revenue (ttm) 1.46M
Net Income (ttm) -15.63M
Shares Out 80.07M
EPS (ttm) -0.20
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 30, 2020
Last Price $1.12
Previous Close $1.16
Change ($) -0.04
Change (%) -3.45%
Day's Open 1.15
Day's Range 1.11 - 1.15
Day's Volume 30,035
52-Week Range 0.50 - 2.50

More Stats

Market Cap 89.68M
Enterprise Value 91.89M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 80.07M
Float 26.57M
EPS (basic) -0.20
EPS (diluted) -0.20
FCF / Share -0.09
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 2.02M
Short Ratio 5.73
Short % of Float 7.59%
Beta 0.50
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 61.40
PB Ratio 19.08
Revenue 1.46M
Operating Income -16.79M
Net Income -15.63M
Free Cash Flow -7.33M
Net Cash -2.22M
Net Cash / Share -0.03
Gross Margin 20.19%
Operating Margin -1,149.72%
Profit Margin -1,070.40%
FCF Margin -501.65%
ROA -81.16%
ROE -232.66%
ROIC -169.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015
Revenue1.551.561.080.62-
Revenue Growth-1.02%44.99%74.8%--
Gross Profit0.340.390.250.54-
Operating Income-19.38-7.63-3.880.08-0.03
Net Income-18.07-7.77-3.460.06-0.03
Shares Outstanding75.1272.0065.0351.146.33
Earnings Per Share-0.24-0.11-0.05--
Operating Cash Flow-7.08-4.40-1.340.01-0.03
Capital Expenditures-0.39-0.50-7.06-0.70-
Free Cash Flow-7.47-4.90-8.40-0.69-0.03
Cash & Equivalents0.762.253.032.890.11
Total Debt3.191.001.50--
Net Cash / Debt-2.431.251.532.890.11
Assets10.4913.4012.673.710.11
Liabilities6.032.145.360.160.12
Book Value4.4712.127.893.55-0.01
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Avalon GloboCare Corp.
Country United States
Employees 7
CEO David K. Jin

Stock Information

Ticker Symbol AVCO
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Unique Identifier NASDAQ: AVCO

Description

Avalon GloboCare, together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. It also develops Avalon Cell and Avalon Rehab platforms that cover the areas of regenerative medicine, cell-based immunotherapy, and exosome technology. In addition, the company develops proprietary diagnostic and therapeutic products leveraging exosome technology; and provides development services for hospitals. The company has a strategic partnership with Weill Cornell Medical College to co-develop bio-production and standardization procedures for chimeric antigen receptor (CAR)-T Therapy; GensKey Medical Technology Co. Ltd. to co-develop and commercialize point-of-care, rapid detection antibody tests to identify whether a patient has been exposed to and has developed antibodies against SARS-CoV-2; GE Healthcare to enhance standardized automation and bio-production for cellular medicines; and HydroPeptide, LLC to co-develop and commercialize various clinical-grade, exosome-based cosmeceutical and orthopedic products, as well as research agreement with Massachusetts Institute of Technology to develop CAR technology. Avalon GloboCare Corp. is headquartered in Freehold, New Jersey.